HK1057749A1 - The hydrochloride salt of 5Ä4-Ä2-(n-methyl-n-(2-pyridyl)amino)ethoxyÜbenzylÜthiazolidine-2,4-dione - Google Patents

The hydrochloride salt of 5Ä4-Ä2-(n-methyl-n-(2-pyridyl)amino)ethoxyÜbenzylÜthiazolidine-2,4-dione

Info

Publication number
HK1057749A1
HK1057749A1 HK03108589A HK03108589A HK1057749A1 HK 1057749 A1 HK1057749 A1 HK 1057749A1 HK 03108589 A HK03108589 A HK 03108589A HK 03108589 A HK03108589 A HK 03108589A HK 1057749 A1 HK1057749 A1 HK 1057749A1
Authority
HK
Hong Kong
Prior art keywords
ethoxyübenzylüthiazolidine
dione
pyridyl
amino
methyl
Prior art date
Application number
HK03108589A
Other languages
English (en)
Inventor
Andrew Simon Craig
Michael Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of HK1057749A1 publication Critical patent/HK1057749A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK03108589A 2000-09-06 2003-11-25 The hydrochloride salt of 5Ä4-Ä2-(n-methyl-n-(2-pyridyl)amino)ethoxyÜbenzylÜthiazolidine-2,4-dione HK1057749A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0021865.1A GB0021865D0 (en) 2000-09-06 2000-09-06 Novel pharmaceutical
PCT/GB2001/003991 WO2002020519A1 (en) 2000-09-06 2001-09-05 The hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione

Publications (1)

Publication Number Publication Date
HK1057749A1 true HK1057749A1 (en) 2004-04-16

Family

ID=9898953

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03108589A HK1057749A1 (en) 2000-09-06 2003-11-25 The hydrochloride salt of 5Ä4-Ä2-(n-methyl-n-(2-pyridyl)amino)ethoxyÜbenzylÜthiazolidine-2,4-dione

Country Status (35)

Country Link
US (3) US20040034066A1 (xx)
EP (1) EP1315723B1 (xx)
JP (1) JP2004508369A (xx)
KR (1) KR100770513B1 (xx)
CN (1) CN100558717C (xx)
AP (1) AP1715A (xx)
AT (1) ATE300538T1 (xx)
AU (2) AU8428401A (xx)
BG (1) BG107607A (xx)
BR (1) BR0113713A (xx)
CA (1) CA2421213A1 (xx)
CY (1) CY1105252T1 (xx)
CZ (1) CZ302125B6 (xx)
DE (1) DE60112310T2 (xx)
DK (1) DK1315723T3 (xx)
DZ (1) DZ3475A1 (xx)
EA (1) EA004296B1 (xx)
EC (1) ECSP034505A (xx)
ES (1) ES2244647T3 (xx)
GB (1) GB0021865D0 (xx)
HK (1) HK1057749A1 (xx)
HU (1) HUP0300938A3 (xx)
IL (2) IL154724A0 (xx)
MA (1) MA25908A1 (xx)
MX (1) MXPA03001956A (xx)
NO (1) NO324020B1 (xx)
NZ (1) NZ524548A (xx)
OA (1) OA12375A (xx)
PL (1) PL360578A1 (xx)
PT (1) PT1315723E (xx)
SI (1) SI1315723T1 (xx)
SK (1) SK2632003A3 (xx)
UA (1) UA74003C2 (xx)
WO (1) WO2002020519A1 (xx)
ZA (1) ZA200301809B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
JP5063714B2 (ja) * 2010-01-29 2012-10-31 シャープ株式会社 画像読取装置及び画像形成装置
EP2508525A1 (en) 2011-04-05 2012-10-10 Bayer Pharma Aktiengesellschaft Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts
RU2487132C1 (ru) * 2012-07-23 2013-07-10 Общество с ограниченной ответственностью "Метаген" Производные циклических 5-нитропиридин-2-ил-тиоалкенил-4-дитиокарбаматов, обладающие противогрибковой активностью, и их применение

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306228B1 (en) * 1987-09-04 1999-11-17 Beecham Group Plc Substituted thiazolidinedione derivatives
US6288095B1 (en) * 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
GB9124513D0 (en) * 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
US5874454A (en) * 1993-09-15 1999-02-23 Warner-Lambert Company Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
DE69711862T2 (de) * 1997-07-17 2002-11-14 Interlemo Holding S.A., Saint-Sulpice Steckverbindungssystem
CN1183130C (zh) * 1999-09-24 2005-01-05 中国人民解放军军事医学科学院毒物药物研究所 噻唑烷类衍生物及其医药用途
GB0006133D0 (en) * 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
US6627646B2 (en) * 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs

Also Published As

Publication number Publication date
KR100770513B1 (ko) 2007-10-25
PT1315723E (pt) 2005-11-30
WO2002020519A1 (en) 2002-03-14
IL154724A0 (en) 2003-10-31
NZ524548A (en) 2004-10-29
ECSP034505A (es) 2003-06-25
ES2244647T3 (es) 2005-12-16
AU2001284284B2 (en) 2005-08-04
SI1315723T1 (en) 2005-10-31
EA004296B1 (ru) 2004-02-26
PL360578A1 (en) 2004-09-06
NO20031020D0 (no) 2003-03-05
EP1315723A1 (en) 2003-06-04
US20070191435A1 (en) 2007-08-16
AU8428401A (en) 2002-03-22
NO20031020L (no) 2003-05-06
DE60112310D1 (de) 2005-09-01
GB0021865D0 (en) 2000-10-18
KR20030027118A (ko) 2003-04-03
IL154724A (en) 2009-07-20
BG107607A (bg) 2003-12-31
AP2003002758A0 (en) 2003-06-30
CA2421213A1 (en) 2002-03-14
SK2632003A3 (en) 2003-12-02
BR0113713A (pt) 2004-07-06
US20050282867A1 (en) 2005-12-22
DZ3475A1 (fr) 2002-03-14
HUP0300938A2 (hu) 2003-11-28
UA74003C2 (en) 2005-10-17
MXPA03001956A (es) 2003-06-24
DK1315723T3 (da) 2005-10-24
US20040034066A1 (en) 2004-02-19
ATE300538T1 (de) 2005-08-15
EP1315723B1 (en) 2005-07-27
DE60112310T2 (de) 2006-02-09
CY1105252T1 (el) 2010-03-03
CN100558717C (zh) 2009-11-11
CN1366520A (zh) 2002-08-28
MA25908A1 (fr) 2003-10-01
CZ2003615A3 (cs) 2003-11-12
AP1715A (en) 2007-02-28
CZ302125B6 (cs) 2010-11-03
HUP0300938A3 (en) 2005-04-28
JP2004508369A (ja) 2004-03-18
EA200300345A1 (ru) 2003-08-28
OA12375A (en) 2004-03-19
NO324020B1 (no) 2007-07-30
ZA200301809B (en) 2004-04-19

Similar Documents

Publication Publication Date Title
AP2002002600A0 (en) Hydrochloride salts of 5-Ä4-Ä2-(n-methyl-n-(2-pyridyl)amino ethoxyÜbenylÜthiazolid ine-2,4-dione
MXPA03006260A (es) Derivados de amina sustituidos y metodos de uso.
ZA200307646B (en) Benzamidine derivative.
IL153508A0 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
IL173726A0 (en) N,n-dihalogenated amino acids and derivatives
SI1429761T1 (sl) Novi 4,5-dihidro-1h-pirazolni derivati s cb1-antagonisticno aktivnostjo
ZA200204397B (en) Nitrile derivatives as cathepsin K inhibitors.
AU2002337749A1 (en) Pioglitazone hydrochloride
MXPA03010020A (es) PROCEDIMIETO PARA LA PREPARACIoN DE UREA.
AU2002306329A1 (en) Aqueous cilostazol preparation for injection
AU2001250892A1 (en) Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and n-(4-methoxyphenyl)-3-chloropropionamide
GC0000250A (en) 5-Ä4-Ä2-(N-methyl-n-(2-pyridyl) amino) ethoxyÜ benzylÜthiazolidine-2,4-dione maleci acid salt
MXPA03007869A (es) Inhibidores peptidicos de desformilasa.
HK1057749A1 (en) The hydrochloride salt of 5Ä4-Ä2-(n-methyl-n-(2-pyridyl)amino)ethoxyÜbenzylÜthiazolidine-2,4-dione
HK1064609A1 (en) 2-(amino-3,4-dioxo-1cyclobuten-1-yl)amino alkyl -acid derivatives for the treatment of pain
ZA200404807B (en) Imidazoquinoline derivatives.
AP2003002767A0 (en) Sodium salts of 5-Ä4-Ä2-(N-methyl-N-(2-pyridyl) amino) ethoxyÜ benzylÜ thazolidine-i, 4-dione
AU2002352386A1 (en) Hydrogensulfate salt of 5-'4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy!benzyl!thia zolidine-2,4-dione
IL157043A0 (en) Aryl carbamate derivatives, preparation and use thereof
IL159561A0 (en) Eurotinones and derivatives thereof, processes for preparing them, and their use
HK1061392A1 (en) 5-'4-'2-(N-methyl-n-(2-pyridyl)amino)ethoxyÜbenzylÜthiazolidine-2,4-dione mesylate salt
AU2001240598A1 (en) N-(1-oxoalkyl)amino or n-alkylaminocarbonyl polyhydroxyalkanecarboxylic acid derivatives
IL164377A0 (en) Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone
AU2002222305A1 (en) 5-'4-'2-(n-methyl-n- (2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione mesylate salt
ZA200305198B (en) Substituted amine derivatives and methods of use.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110905